Home▸Articles▸HIV Antiretroviral Therapy Management

Understanding HIV Drug Resistance Genotype Testing

A critical tool in the fight against HIV, genotype testing reveals viral genetic mutations that can lead to drug resistance.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What Genotype Testing Is

Genotype testing is a method used to identify specific genetic mutations in the human immunodeficiency virus (HIV) that can affect its response to antiretroviral drugs. By analyzing viral RNA or DNA, genotype tests can detect these mutations and help guide treatment decisions.

This process involves sequencing parts of the HIV genome, typically focusing on regions known to be associated with drug resistance. The results provide a 'genotype profile' that healthcare providers use in conjunction with clinical data to select appropriate antiretroviral therapy.

How Genotype Testing Works

During genotype testing, the viral genetic material is extracted and sequenced. The sequence information is then compared against a database of known HIV mutations that confer resistance to specific drugs. This comparison identifies which mutations are present in the patient's virus.

The presence or absence of these mutations can indicate whether certain antiretroviral drugs will be effective for the patient, helping to avoid treatment failures and reducing the risk of developing drug-resistant strains of HIV.

live demo · related simulation● LIVE

Why It Matters

HIV drug resistance is a significant challenge in managing the disease. Without proper testing, patients may receive ineffective treatments that fail to control viral replication, leading to higher viral loads and increased risk of complications.

By using genotype testing, healthcare providers can tailor antiretroviral therapy to each patient's specific viral profile, improving treatment outcomes and reducing the spread of drug-resistant HIV strains.

Real-World Examples

For example, if a patient has a genotype test revealing the K103N mutation in reverse transcriptase, this indicates resistance to several nucleoside reverse transcriptase inhibitors (NRTIs). This information guides the healthcare provider to choose non-NRTI-based regimens.

Another instance involves the presence of the Y181C mutation, which confers resistance to efavirenz. In such cases, alternative drugs like raltegravir or dolutegravir are often prescribed.

Frequently asked questions

How accurate is genotype testing for HIV drug resistance?

Genotype testing is generally highly accurate but can sometimes miss mutations that do not significantly impact viral replication. Regular monitoring and follow-up tests may be necessary to ensure ongoing effectiveness of the treatment regimen.

Can genotype testing predict future drug resistance in patients with HIV?

While genotype testing cannot predict future mutations, it can help identify existing genetic factors that might lead to drug resistance. Regular monitoring and additional tests may be needed to detect new mutations as they arise.

Is genotype testing the only method for managing HIV antiretroviral therapy?

No, while genotype testing is a critical tool, it is often used in conjunction with other methods such as phenotype testing and clinical assessment. These combined approaches provide a comprehensive understanding of the patient's viral profile.

How frequently should genotype tests be performed for HIV patients?

Genotype tests are typically recommended at initial diagnosis, before starting treatment, and periodically during therapy to monitor for drug resistance. The frequency can vary based on individual patient needs and clinical guidelines.

Try it live

Everything above runs in your browser — open HIV Drug Resistance Genotype Testing Simulator and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open HIV Drug Resistance Genotype Testing Simulator simulation

What did you find?

Add reproduction steps (optional)